Quick Answer
Alpha Tau Medical Ltd. reported Diluted EPS of $0.53 per share (loss) for fiscal year 2025.
Alpha Tau Medical Ltd. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.53 | -17.8% |
| 2024 | -$0.45 | -7.1% |
| 2023 | -$0.42 | +20.8% |
| 2022 | -$0.53 | +20.9% |
| 2021 | -$0.67 | -204.5% |
| 2020 | -$0.22 | +12.0% |
| 2019 | -$0.25 | — |
- Alpha Tau Medical Ltd. showed a decrease of -17.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, Alpha Tau Medical Ltd.’s diluted eps has declined by 112.0% (from $0.25 per share (loss) to $0.53 per share (loss)).
- The most recent figure is from Alpha Tau Medical Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: